Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016 According to market demands
©
Global Markets Directs, Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016, provides in depth analysis on Calcitonin Gene Related Peptide (CGRP) targeted pipeline therapeutics.
The report provides comprehensive information on the Calcitonin Gene Related Peptide (CGRP), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Calcitonin Gene Related Peptide (CGRP) targeted therapeutics development and features dormant and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Download Sample copy of this Report at : http://www.marketresearchreports.biz/sample/sample/726754
Scope
- The report provides a snapshot of the global therapeutic landscape for Calcitonin Gene Related Peptide (CGRP)
- The report reviews Calcitonin Gene Related Peptide (CGRP) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Calcitonin Gene Related Peptide (CGRP) targeted therapeutics and enlists all their major and minor projects
- The report assesses Calcitonin Gene Related Peptide (CGRP) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Calcitonin Gene Related Peptide (CGRP) targeted therapeutics
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Calcitonin Gene Related Peptide (CGRP)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Calcitonin Gene Related Peptide (CGRP) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Browse Latest News at http://www.marketresearchreports.biz/articles
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Calcitonin Gene Related Peptide (CGRP) Overview 6
Therapeutics Development 7
Calcitonin Gene Related Peptide (CGRP) - Products under Development by Stage of Development 7
Calcitonin Gene Related Peptide (CGRP) - Products under Development by Therapy Area 8
Calcitonin Gene Related Peptide (CGRP) - Products under Development by Indication 9
Calcitonin Gene Related Peptide (CGRP) - Pipeline Products Glance 10
Late Stage Products 10
Early Stage Products 11
Calcitonin Gene Related Peptide (CGRP) - Products under Development by Companies 12
Calcitonin Gene Related Peptide (CGRP) - Therapeutics Assessment 14
Assessment by Monotherapy/Combination Products 14
Assessment by Mechanism of Action 15
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Calcitonin Gene Related Peptide (CGRP) - Companies Involved in Therapeutics Development 21
Alder Biopharmaceuticals Inc. 21
BCN Peptides, S.A. 22
Boehringer Ingelheim GmbH 23
Eli Lilly and Company 24
BCN Peptides, S.A. 25
Teva Pharmaceutical Industries Ltd. 26
Noxxon Pharma AG 27
Calcitonin Gene Related Peptide (CGRP) - Drug Profiles 28
ALD-403 - Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
DD-04107 - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
galcanezumab - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
NOXL-41 - Drug Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
olcegepant - Drug Profile 35
Product Description 35
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz